Stargazer Pharmaceuticals

Recent Finacing

Series A

Recent Raise

$57M

Stargazer Pharmaceuticals is a Boston-based biopharmaceutical company developing STG-001, a proprietary therapy for Stargardt disease, focusing on treatments for rare inherited retinal disorders and collaborating with FFB.

Founded 2018

Massachusetts, United States

1-10

Private

stargazerpharmaceuticals.com

Highlights

Focus Areas

Manufacturing

Pharmaceutical

Recent Investors

Financials

$57M

Total Raised

1

Funding round

5

Investors

Team

Upgrade to view the team

See the team members at Stargazer Pharmaceuticals.